Effects of 17-AAG on Choline Metabolism in Breast Cancer Cells
Author Information
Author(s): Alissa H Brandes, Christopher S Ward, Sabrina M Ronen
Primary Institution: University of California, San Francisco
Hypothesis
Does 17-allyamino-17-demethoxygeldanamycin (17-AAG) treatment affect choline metabolism in breast cancer cells?
Conclusion
17-AAG treatment significantly increases intracellular choline, phosphocholine, and glycerophosphocholine levels in breast cancer cells.
Supporting Evidence
- 17-AAG treatment increased intracellular choline levels to 266% of control.
- Phosphocholine levels rose to 181% of control after 17-AAG treatment.
- Glycerophosphocholine levels increased to 176% of control following treatment.
Takeaway
When breast cancer cells are treated with a drug called 17-AAG, they take in more choline, which is important for their growth.
Methodology
MCF-7 breast cancer cells were treated with 17-AAG, and magnetic resonance spectroscopy was used to measure metabolite levels.
Limitations
The study primarily focused on a single breast cancer cell line, which may limit the generalizability of the findings.
Statistical Information
P-Value
0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website